BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15268653)

  • 1. Safety of droperidol in behavioural emergencies.
    Shale JH; Shale CM; Mastin WD
    Expert Opin Drug Saf; 2004 Jul; 3(4):369-78. PubMed ID: 15268653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.
    Shale JH; Shale CM; Mastin WD
    J Clin Psychiatry; 2003 May; 64(5):500-5. PubMed ID: 12755651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droperidol in the emergency department: is it safe?
    Richards JR; Schneir AB
    J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

  • 7. Droperidol's effect on QT interval.
    Martinez JB; Moos DD; Dahlen LL
    J Perianesth Nurs; 2006 Apr; 21(2):82-7. PubMed ID: 16600828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
    Halloran K; Barash PG
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):423-7. PubMed ID: 20446348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency medicine updates: Droperidol.
    Cisewski D; Long B; Gottlieb M
    Am J Emerg Med; 2022 Mar; 53():180-184. PubMed ID: 35063889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Droperidol-induced proarrhythmia: the beginning of an answer?
    Charbit B; Funck-Brentano C
    Anesthesiology; 2007 Oct; 107(4):524-6. PubMed ID: 17893444
    [No Abstract]   [Full Text] [Related]  

  • 11. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.
    Michalets EL; Smith LK; Van Tassel ED
    Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droperidol--behind the black box warning.
    Horowitz BZ; Bizovi K; Moreno R
    Acad Emerg Med; 2002 Jun; 9(6):615-8. PubMed ID: 12045077
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 14. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
    Cole JB; Lee SC; Martel ML; Smith SW; Biros MH; Miner JR
    West J Emerg Med; 2020 Jul; 21(4):728-736. PubMed ID: 32726229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warnings strengthened on tranquilizer inapsine (Droperidol).
    SoRelle R
    Circulation; 2001 Dec; 104(25):E9061-2. PubMed ID: 11748130
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 17. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
    Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droperidol transiently prolongs the QT interval in children undergoing single ventricle palliation.
    Scott JP; Stuth EA; Stucke AG; Cava JR; Berens RJ
    Pediatr Cardiol; 2015 Jan; 36(1):196-204. PubMed ID: 25087057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.